Sutro Biopharma, Inc.
STRO
$40.05
-$0.86-2.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -191.09M | -216.77M | -208.70M | -245.22M | -227.46M |
| Total Depreciation and Amortization | 7.32M | 7.57M | 7.47M | 7.36M | 7.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.93M | 57.48M | 34.95M | 26.81M | 19.80M |
| Change in Net Operating Assets | -50.40M | -70.81M | -82.58M | 16.37M | 8.90M |
| Cash from Operations | -177.23M | -222.53M | -248.86M | -194.68M | -191.54M |
| Capital Expenditure | -1.70M | -2.58M | -3.16M | -3.83M | -3.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.71M | 116.38M | 224.26M | 141.97M | 221.61M |
| Cash from Investing | 45.01M | 113.80M | 221.10M | 138.15M | 218.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -4.08M |
| Issuance of Common Stock | 376.00K | 373.00K | 1.34M | 97.86M | 98.65M |
| Repurchase of Common Stock | -332.00K | -289.00K | -338.00K | -315.00K | -509.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 44.00K | 84.00K | 999.00K | 97.55M | 94.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -132.17M | -108.65M | -26.76M | 41.01M | 121.02M |